Google
 
Google

World Stem Cell Summit 2010

Thursday, November 27, 2008

Nature Clinical Practice Rheumatology - Table of Contents alert Volume 4 Issue 12

NATURE CLINICAL PRACTICE RHEUMATOLOGY

December 2008 Volume 4 Number 12

Visit Nature Clinical Practice Rheumatology online to browse the journal.

Now available at http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0pMu0Ea

"Officially endorsed by the Asia Pacific League of Associations for
Rheumatology"

====================================================================

Special Focus on Glycobiology of the Immune System brought to you by
Immunology & Cell Biology

Bringing you the latest on the glycobiology of the immune system, this
special feature and accompanying web focus explore the current
understanding of how glycans play a role in activating the adaptive
and innate immune responses.

To view this special offer FREE of charge visit
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0B7tE0Ea

====================================================================

----------------------
EDITORIAL
----------------------
A growing crisis in confidence
Peter E Lipsky
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYK0ES

----------------------
RESEARCH HIGHLIGHTS
----------------------
Adalimumab suppresses markers of structural damage in ankylosing
spondylitis
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYL0ET

IgG4+ multi-organ lymphoproliferative syndrome: a new clinical entity?
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYM0EU

Oral vaccine protects against disease in a mouse model of RA
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYN0EV

Novel anti-CD20 monoclonal antibody shows promise as therapy for RA
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYO0EW

Ten-second RAPID3 tool categorizes RA disease severity similarly to
standard indices
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYP0EX

Pegloticase reduces serum urate levels in patients with
treatment-refractory gout
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYQ0EY

Belimumab is well tolerated and depletes B cells effectively in patients
with SLE
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYR0EZ

In briefs
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYS0Ea

----------------------
GUIDELINES SUMMARY
----------------------
Screening for osteoporosis in men: comment on the American College of
Physicians clinical guidelines
Marc C Hochberg and Robert A Adler
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYT0Eb

----------------------
PRACTICE POINTS
----------------------
Is long-term etanercept therapy safe and effective in patients with
juvenile RA?
Raphael Hirsch
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYU0Ec

Do wedged insoles improve outcomes in patients with knee osteoarthritis?
Jeffrey N Katz
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYV0Ed

----------------------
CLINICAL ADVANCES
----------------------
Are patients with RA at increased risk of malignancy?
Kimme L Hyrich
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYW0Ee

Denosumab-a novel strategy to prevent structural joint damage in
patients with RA?
Georg Schett and Jean-Pierre David
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYX0Ef

First pregabalin and now duloxetine for fibromyalgia syndrome: closer
to a brave new world?
Chad S Boomershine
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYY0Eg

----------------------
VIEWPOINT
----------------------
The importance of recognizing scleroderma-type disorders in clinical
practice
Laura K Hummers
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYZ0Eh

----------------------
REVIEWS
----------------------
Issues in the design of new clinical trials for rheumatoid arthritis
therapeutics
William D Schwieterman
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYa0Eo

Mycobacterial disease in patients with rheumatic disease
Jakko van Ingen, Martin J Boeree, PN Richard Dekhuijzen and Dick van
Soolingen
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYb0Ep

Activated B cells in autoimmune diseases: the case for a regulatory
role
Stephen M Anderton and Simon Fillatreau
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYc0Eq

Common mistakes in the clinical use of bone mineral density testing
E Michael Lewiecki and Nancy E Lane
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYd0Er

----------------------
CASE STUDY
----------------------
Painful knee locking caused by gouty tophi successfully treated with
allopurinol
Soumya Chatterjee and Hakan Ilaslan
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYe0Es

=====================================================================

You have been sent this Table of Contents Alert because you have opted
in to receive it. You can change or discontinue your e-mail alerts at
any time, by modifying your preferences on your nature.com account at:
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0Zzu0Ex
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department:
registration@nature.com

For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com

For other enquiries, please contact our customer feedback department:
feedback@nature.com

Nature Publishing Group | 75 Varick Street, 9th Floor | New York |
NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne -
San Diego - San Francisco - Washington - New York - Boston

=====================================================================

Google

Any Comments ?.......

E-mail: manojhind2001us@gmail.com
Google
 

World Time